Source: The Street
Date: 1 december 2009
Author: Adam Feuerstein
URL: The Street
Hemispherx BioPharma(HEB Quote) said late Tuesday night that the Food and Drug Administration refused to approve the experimental drug Ampligen for use in patients with chronic fatigue syndrome.


0 comments:
Legg inn en kommentar